BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 4, 2021
View Archived Issues
Lysogene initiates phase I/II study of LYS-GM101 gene therapy in infantile GM1 gangliosidosis
Read More
FDA approves IND for KRAS G12C inhibitor JAB-21822
Read More
SAN-903 reduces lung inflammation and fibrosis in mouse model of IPF
Read More
First direct KRAS G12V(ON) inhibitors developed at Revolution Medicines
Read More
New model allows exploration of PHF21B gene function
Read More
Promising part A data from MOMENTUM study of SRP-5051 in DMD
Read More
Promising safety data from first dose cohort of phase I study evaluating DSG3-CAART
Read More
Shanghai HaiHe Biopharma patents BRD4 inhibitors
Read More
Janssen Biotech presents DHODH inhibitors
Read More
New IDH1 inhibitors presented by Shanghai Meton Pharmaceutical
Read More
Kallyope discloses GPR119 agonists
Read More
Avacta Life Sciences presents new PD-L1 inhibitors
Read More
Topline data presented from first cohort of phase Ib trial of RGLS-4326
Read More
BRM-421: human study data for dry eye syndrome
Read More
Novavax announces pediatric expansion of pivotal PREVENT-19 trial of NVX-CoV-2373
Read More
Ongoing TOGETHER platform study will evaluate Lambda in outpatients with COVID-19
Read More
HORNBILL phase I data reported for BI-764524
Read More
DF-6002 shows robust antitumor activity in preclinical models
Read More
Discovery and optimization of novel N-pyrimidines as IDO1 inhibitors
Read More
Administration of 5,6-DiHETE, an endogenous TRPV4 antagonist, contributes to colitis healing in mice
Read More
Mitochondrial peptide causes septic shock nosocomials, mortality
Read More
LRRK2 inhibitor DNL-151 well tolerated in healthy volunteers and patients with PD
Read More
XBiotech and INSERM collaborate on phase II/III trial of XB-2001
Read More
Vaxart reports phase I findings on oral COVID-19 vaccine VXA-CoV2-1
Read More
FDA clears IND for phase II trial of CT-868 in overweight and obese patients with type 2 diabetes
Read More
FDA approves Kloxxado for opioid overdose
Read More
Merus begins phase I/II study of MCLA-129 in NSCLC and solid tumors
Read More
PXS-5505 to enter preclinical evaluation for glioblastoma
Read More
